Sanofi announced on May 21 that it has reached an agreement with Formation Bio and OpenAI to cooperate to build AI-driven software to accelerate drug development and provide patients with new drugs more efficiently. Sanofi said the partnership with OpenAI will enable it to access proprietary data, while Formation Bio will provide additional engineering resources.
赛诺菲、Formation Bio和OpenAI合作，将利用AI驱动软件加速药物开发
Sanofi, Formation Bio, and OpenAI collaborate to accelerate drug development with AI-driven software
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.